General Information of the Compound
Compound ID |
CP0374443
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
3-[[2-[5-cyclohexyl-1-(3,3-dimethyl-2-oxobutyl)-2-oxo-1,3,4-benzotriazepin-3-yl]acetyl]amino]-N-methylsulfonylbenzamide
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C30H37N5O6S
|
||||||||||||||||||
Molecular Weight |
595.722
|
||||||||||||||||||
Canonical SMILES |
CC(C)(C)C(=O)CN1c2ccccc2C(=NN(CC(=O)Nc2cccc(c2)C(=O)NS(C)(=O)=O)C1=O)C1CCCCC1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C30H37N5O6S/c1-30(2,3)25(36)18-34-24-16-9-8-15-23(24)27(20-11-6-5-7-12-20)32-35(29(34)39)19-26(37)31-22-14-10-13-21(17-22)28(38)33-42(4,40)41/h8-10,13-17,20H,5-7,11-12,18-19H2,1-4H3,(H,31,37)(H,33,38)
Show/Hide
|
||||||||||||||||||
InChIKey |
XTIUEMKXEZCGSM-UHFFFAOYSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00958, Cholecystokinin receptor type A
Protein ID: PT01124, Gastrin/cholecystokinin type B receptor